In patients with lung cancer that had spread to the brain, we saw EGFR alterations were most identified in intracranial-only progression (67%) as compared to both CNS and extracranial-progression (40%) and extracranial-only progression (37%), P = .08. Here, EGFR is linked to lung cancer.